Giant cell arteritis in the elderly

Abrar-Ahmad Zulfiqar1, Marine Richard2, Carl Arndt3

  • 1Département de médecine interne, diabète et maladies métaboliques, Clinique médicale B, Hôpitaux universitaires de Strasbourg, Strasbourg, France

Insights

Giant cell arteritis (GCA) outcomes show no significant differences between patients aged 75 or younger and those older than 75. However, aortitis was less prevalent in older patients, who also had shorter follow-up periods.

Area of Science:

  • Rheumatology
  • Vascular Medicine
  • Geriatric Medicine

Context:

  • Giant cell arteritis (GCA), also known as Horton’s disease, is an inflammatory condition affecting large and medium-sized arteries.
  • It predominantly affects individuals aged 50 and older, with a peak incidence between 70 and 80 years.
  • Limited clinical data exists for GCA patients over 80 years old.

Purpose:

  • To evaluate and compare the impact of age on the diagnosis, treatment, and prognosis of GCA.
  • To analyze differences in GCA presentation and outcomes between patients aged 75 or younger and those older than 75.

Summary:

  • A retrospective study of 67 GCA patients (2012-2017) divided them into two age groups: ≤75 and >75 years.
  • No statistically significant differences in mortality or overall outcomes were observed between the age groups.
  • Aortitis was less common in patients over 75, while those 75 or younger experienced more relapses, potentially due to shorter follow-up.

Impact:

  • This study provides insights into GCA management in elderly populations.
  • Findings suggest age itself may not be a critical prognostic factor, but specific manifestations like aortitis may differ.
  • Highlights the need for tailored follow-up strategies considering potential differences in disease presentation and relapse rates.
Abstract

Related Concept Videos

Aging01:26

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
151
The Effect of Aging on Tissues01:19

The Effect of Aging on Tissues

Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
2.2K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
19
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
14.0K
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
31
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
24